This bill prohibits a pharmacy benefit manager (PBM) or health carrier from requiring that a clinician-administered drug or its administration be covered as a pharmacy benefit. The bill also sets other requirements that PBMs and health carriers must comply with when providing coverage and reimbursement for clinician-administered drugs. This bill in part addresses what is sometimes called “white bagging” — a process under which a specialty pharmacy ships a prescription directly to a health care provider, to be held by that provider until the patient receives treatment from the provider. This can be contrasted with a “buy-and-bill” process under which a health care provider directly purchases the prescription drug and then administers that drug to the patient.